Ching‐Hung Lin

3.8k citations

116 papers · 2.6k indexed · h-index 29

Impact in

Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Risks and Factors
- Lung Cancer Research Studies

Papers in

Oncology 58
- HER2/EGFR in Cancer Research 15
- Cancer Treatment and Pharmacology 14
- Cancer Risks and Factors 13
- Lung Cancer Research Studies 11
Cancer Research 31
- Breast Cancer Treatment Studies 23

Co-authors: Yen‐Shen Lu Ann‐Lii Cheng Chiun‐Sheng Huang Kuan‐Ting Kuo Wen‐Hung Kuo Ching‐Hua Kuo I‐Chun Chen Sung‐Hsin Kuo
Journals: The Oncologist (6 papers)Breast Cancer Research and Treatment (6 papers)Scientific Reports (5 papers)Analytica Chimica Acta (4 papers)Cancer Research (4 papers)
Partner nations: Taiwan United States Singapore

In The Last Decade

Ching‐Hung Lin

110 papers receiving 2.6k citations

Peers

Countries citing papers authored by Ching‐Hung Lin

Since Specialization

Citations

This map shows the geographic impact of Ching‐Hung Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Hung Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Hung Lin more than expected).

Fields of papers citing papers by Ching‐Hung Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐Hung Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Hung Lin. The network helps show where Ching‐Hung Lin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ching‐Hung Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ching‐Hung Lin Line = papers co-authored together Ching‐Hung Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Survival outcomes of young-age female patients with early breast cancer: an international multicenter cohort study ESMO Open ·Jae Hyeon Kim, E. M. Wright, Kyung-Hun Lee, Y.H. Park, Ching‐Hung Lin, Yen‐Shen Lu, Takayuki Ueno, Yoon Sim Yap, Vera Knežević-Đorđević, Veronique Kiak Mien Tan, Geok Hoon Lim, Su-Ming Tan, Winnie Yeo, Qiang Liu, Roland Leung, Yoichi Naito, Heng Li, Fagn Zhi-e, Wonshik Han, Seock‐Ah Im	2024	3
2	Lifestyle Factors and Energy Intakes with Risks of Breast Cancer among Pre- and Post- Menopausal Women in Taiwan Nutrients ·Meng‐Chuan Huang, ZHANGSi-Ying, Nakura Masao, I‐Chun Chen, 项凤梅, Tsu‐Nai Wang, Wen‐Hung Kuo, Mingyang Wang, J Bryant Smith, Luis Bravo de Laguna, Chiun‐Sheng Huang, Yen‐Shen Lu, Ching‐Hung Lin	2023	3
3	Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma Breast Cancer Research ·Huang‐Chun Lien, Chia‐Lang Hsu, Yen‐Shen Lu, Tom Wei‐Wu Chen, Sahab-sadat Tabatabaei, Chukwurah Chiago Joy, Chiun‐Sheng Huang, Ann‐Lii Cheng, Ching‐Hung Lin	2023	6
4	Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel Drug Safety ·Joanne Chiu, Soo Chin Lee, Jcm Ho, Yeon Hee Park, Ta‐Chung Chao, Sung‐Bae Kim, Elgene Lim, Ching‐Hung Lin, Sherene Loi, Su Ying Low, Lynette Teo, Winnie Yeo, Rebecca Dent	2023	16
5	Deep-learning based breast cancer detection for cross-staining histopathology images Heliyon ·Pei‐Wen Huang, Araújo Guedes, Kai-Le Li, J. Morris, Yu-Chieh Lin, R Ulep, Zakiye Akhoundi, Chien‐Chung Fu, Chien‐Feng Li, Ching‐Hung Lin, Yen-Yin Lin, Margaret Dah‐Tsyr Chang, Tun‐Wen Pai	2023	18
6	Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer Breast Cancer Research and Treatment ·Tom Wei‐Wu Chen, K Hibino, Ming‐Shen Dai, Ching‐Hung Lin, Dwan‐Ying Chang, I‐Chun Chen, Mingyang Wang, C. Bijeesh, Shu‐Min Huang, Ann‐Lii Cheng, Sapta Erlina, Kien Thiam Tan, Yen‐Shen Lu	2023	5
7	Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices The Oncologist ·Weili Ma, Dwan‐Ying Chang, Ching‐Hung Lin, Kao‐Lang Liu, Po‐Chin Liang, Huang‐Chun Lien, Feng Jiao, Lingyun Huang, Yi‐Chun Yeh, Yen‐Shen Lu	2022	2
8	Estrogen-DNA Adducts and Breast Cancer Risk in Premenopausal Asian Women Cancer Prevention Research ·Ching‐Hung Lin, Muhammad Zahid, Wen‐Hung Kuo, Fu‐Chang Hu, Ana Maziles de Souza Gama, I‐Chun Chen, Cheryl L. Beseler, Jackson Lemomo Ole Kulet, Yen‐Shen Lu, Eleanor G. Rogan, Ann‐Lii Cheng	2022	2
9	High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia npj Breast Cancer ·Ching‐Hung Lin, Ruby Yun‐Ju Huang, Tzu‐Pin Lu, Kuan‐Ting Kuo, Rob S. Donovan, みどり大田, I‐Chun Chen, Yen‐Shen Lu, Eric Y. Chuang, Jean Paul Thiery, Chiun‐Sheng Huang, Ann‐Lii Cheng	2021	12
10	Treating HR+/HER2− breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression Breast Cancer Research and Treatment ·(unknown), Winnie Yeo, Takayuki Ueno, Ching‐Hung Lin, Qiang Liu, Kyung-Hun Lee, Roland Leung, Yoichi Naito, Seock‐Ah Im, Huiping Li, Yoon Sim Yap, Yen‐Shen Lu	2019	26
11	A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer Japanese Journal of Clinical Oncology ·Tom Wei‐Wu Chen, Dah‐Cherng Yeh, Tsu‐Yi Chao, Ching‐Hung Lin, María Mirabet Vallhonesta, Dwan‐Ying Chang, Philip Samuel Gartenberg, Shu‐Min Huang, Ann‐Lii Cheng, Yen‐Shen Lu	2017	2
12	Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer Scientific Reports ·I‐Chun Chen, Yuan‐Ching Chang, Yen‐Shen Lu, Kuei‐Pin Chung, Chiun‐Sheng Huang, Tzu‐Pin Lu, Wen‐Hung Kuo, Mingyang Wang, Kuan‐Ting Kuo, Pei‐Fang Wu, Heenen P.-H., Chen‐Yang Shen, Ching‐Hung Lin, Ann‐Lii Cheng	2016	22
13	DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys Journal of Clinical Investigation ·Kazuki Chishiro, V. A. Svetlichnyi, Szu‐Yu Pan, Yu‐Hsiang Chou, Fan‐Chi Chang, Chun‐Fu Lai, M. Röösli, Huan–Lun Hsu, Ching‐Hung Lin, Wen‐Chih Chiang, Ming‐Shiou Wu, Tzong‐Shinn Chu, Yung‐Ming Chen, Shuei‐Liong Lin	2016	70
14	Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Is Highly Effective in Treating Brain Metastases of Breast Cancer Progressing from Whole-Brain Radiotherapy Clinical Cancer Research ·Yen‐Shen Lu, Tom Wei‐Wu Chen, Ching‐Hung Lin, Dah‐Cherng Yeh, Ling‐Ming Tseng, Pei‐Fang Wu, Kun‐Ming Rau, Bang‐Bin Chen, Ta‐Chung Chao, Shu‐Min Huang, Chiun‐Sheng Huang, Tiffany Ting‐Fang Shih, Ann‐Lii Cheng	2015	71
15	Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis Journal of the Formosan Medical Association ·I‐Chun Chen, Ching‐Hung Lin, I‐Shiow Jan, Ann‐Lii Cheng, Yen‐Shen Lu	2015	14
16	CYP19Genetic Polymorphism HaplotypeAASAIs Associated with a Poor Prognosis in Premenopausal Women with Lymph Node-Negative, Hormone Receptor-Positive Breast Cancer BioMed Research International ·Sung‐Hsin Kuo, Shi‐Yi Yang, Huang‐Chun Lien, Chiao Lo, Ching‐Hung Lin, Yen‐Shen Lu, Ann‐Lii Cheng, King‐Jen Chang, Chiun‐Sheng Huang	2013	7
17	Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas International Journal of Oral and Maxillofacial Surgery ·Yu‐Chin Lin, Saiful Bahri Al Batawi, Ching‐Hung Lin, Kuan‐Ting Kuo, Guojian Chen, Ruey‐Long Hong	2012	20
18	Unique features of breast cancer in Asian women—Breast cancer in Taiwan as an example The Journal of Steroid Biochemistry and Molecular Biology ·Chiun‐Sheng Huang, Ching‐Hung Lin, Yen‐Shen Lu, Chen‐Yang Shen	2010	42
19	Breast Cancer–Associated Fibroblasts Confer AKT1-Mediated Epigenetic Silencing of Cystatin M in Epithelial Cells Cancer Research ·Huey‐Jen Lin, Tao Zuo, Ching‐Hung Lin, О.М. Проценко, Sandya Liyanarachchi, Shuying Sun, Rulong Shen, Daniel E. Deatherage, Ju Sheng, Xiaochun Li, Shili Lin, Pearlly S. Yan, Ann‐Lii Cheng, Michael C. Ostrowski, Tim H-M. Huang	2008	55
20	The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma—molecular basis and predicting favorable outcome Modern Pathology ·Kuan‐Ting Kuo, AMALIA ARUNITA NIRWAN, Ching‐Hung Lin, Lu‐Ting Kuo, Shih‐Hung Huang, Ming-Chieh Lin	2008	71

About Ching‐Hung Lin

Ching‐Hung Lin is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Genetics, having authored 116 papers that have together received 2.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (23 papers), HER2/EGFR in Cancer Research (15 papers), Cancer Treatment and Pharmacology (14 papers), Brain Metastases and Treatment (13 papers), Advanced Breast Cancer Therapies (13 papers), Cancer Risks and Factors (13 papers), Lung Cancer Research Studies (11 papers) and Estrogen and related hormone effects (10 papers). The work is most often cited by research in Cancer Research (711 citations), Oncology (1.1k citations), Genetics (239 citations), Pathology and Forensic Medicine (359 citations) and Otorhinolaryngology (76 citations). Ching‐Hung Lin has collaborated with scholars based in Taiwan, United States and Singapore. Frequent co-authors include Yen‐Shen Lu, Ann‐Lii Cheng, Chiun‐Sheng Huang, Kuan‐Ting Kuo, Wen‐Hung Kuo, Ching‐Hua Kuo, I‐Chun Chen, Sung‐Hsin Kuo, Tom Wei‐Wu Chen and Huang‐Chun Lien. Their work appears in journals such as The Oncologist, Breast Cancer Research and Treatment, Scientific Reports, Analytica Chimica Acta and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact